Sign Up to like & get
recommendations!
0
Published in 2020 at "Critical Reviews in Clinical Laboratory Sciences"
DOI: 10.1080/10408363.2020.1829537
Abstract: Abstract Mixed phenotype acute leukemia (MPAL) is a heterogeneous group of leukemias that are defined immunophenotypically by antigen expression on blasts of both myeloid and lymphoid lineage. With the exception of BCR-ABL positive and KMT2A…
read more here.
Keywords:
phenotype acute;
acute leukemia;
leukemia;
mixed phenotype ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "International Journal of Laboratory Hematology"
DOI: 10.1111/ijlh.13988
Abstract: Myeloperoxidase (MPO) is considered a specific marker of myeloid/non‐monocytic lineage in the diagnosis of mixed phenotype acute leukemia (MPAL). However, the clinical significance of isolated dim MPO expression in otherwise typical B lymphoblastic leukemia (B‐ALL;…
read more here.
Keywords:
mixed phenotype;
phenotype acute;
leukemia;
acute leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Chemotherapy"
DOI: 10.1159/000524182
Abstract: A combination of azacitidine and venetoclax (AZA-VEN) has been approved for the treatment of adult treatment-naïve acute myeloid leukemia (AML) patients, ineligible for intensive chemotherapy. The protocol may also constitute an alternative for the treatment…
read more here.
Keywords:
mixed phenotype;
phenotype acute;
leukemia;
patient ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24065260
Abstract: Mixed-phenotype acute leukemia (MPAL), a rare and heterogeneous category of acute leukemia, is characterized by cross-lineage antigen expression. Leukemic blasts in MPAL can be represented either by one population with multiple markers of different lineages…
read more here.
Keywords:
mixed phenotype;
leukemic populations;
acute leukemia;
phenotype acute ... See more keywords